Larimar Therapeutics Inc（LRMR）价格预测

$2.440

+0.368 (+15.09%)收盘时

价格预测

1-Day Price Prediction

+2.18%

1-Week Prediction

+4.28%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

LRMR 相似图表分析预测

Alphio's LRMR stock price prediction model matches the current Larimar Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.47 (+2.18%). The 1-week path is $2.52 (+4.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Larimar Therapeutics Inc 股票吗？

Larimar Therapeutics Inc (LRMR) is a good buy right now at a current price of $1.985, especially considering the analyst price targets ranging from $10 to $14, which suggests significant upside potential. The company's lead product, nomlabofusp, is projected to launch commercially in 2027, with first-year sales estimates of $47.9 million and potential peak sales exceeding $1.1 billion by 2040. However, the main risk is the company's current negative net income, which was reported at -32.8 million in Q2 2026, indicating ongoing financial challenges.

LRMR 股价于 Tuesday 收于 $2.44，此前上涨 +15.09%

Larimar Therapeutics Inc (LRMR) last closed at $2.42, losing -0.82%. These facts feed the 1-day and 1-week LRMR price prediction above.

预测驱动因素

Larimar Therapeutics Inc（LRMR）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 LRMR 最接近的股票，按相似度排序。

CTSH

94.30%

-4.05%

LRMR 季节性分析

Historically the probability of a positive October return for LRMR is 68.85%. September offers the highest probability of a positive month at 72.58%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…